| Literature DB >> 25393403 |
Yih-Yuan Chen1, Fan-Chen Tseng2, Jia-Ru Chang1, Shu-Chen Kuo1, Jen-Jyh Lee3, Jun-Jun Yeh4, Tzong-Shi Chiueh5, Jun-Ren Sun5, Ih-Jen Su1, Horng-Yunn Dou1.
Abstract
Tuberculosis incidence among aborigines is significantly higher than for Han Chinese in Taiwan, but the extent to which Mycobacterium tuberculosis (MTB) strain characteristics contribute to this difference is not well understood. MTB isolates from aborigines and Han Chinese living in eastern and southern Taiwan, the major regions of aborigines, were analyzed by spoligotyping and 24-loci MIRU-VNTR. In eastern Taiwan, 60% of aboriginal patients were ≤20 years old, significantly younger than the non-aboriginal patients there; aborigines were more likely to have clustered MTB isolates than Han Chinese (odds ratio (OR) = 5.98, p<0.0001). MTB lineages with high clustering were EAI (54.9%) among southern people, and Beijing (62.5%) and Haarlem (52.9%) among eastern aborigines. Resistance to first-line drugs and multidrug resistance (MDR) were significantly higher among eastern aborigines (≥15%) than in any other geographic and ethnic group (p<0.05); MDR was detected in 5 of 28 eastern aboriginal patients ≤20 years old. Among patients from the eastern region, clustered strains (p = 0.01) and aboriginal ethnicity (p = 0.04) were independent risk factors for MDR. The lifestyles of aborigines in eastern Taiwan may explain why the percentage of infected aborigines is much higher than for their Han Chinese counterparts. The significantly higher percentage of the MDR-MTB strains in the aboriginal population warrants close attention to control policy and vaccination strategy.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25393403 PMCID: PMC4231046 DOI: 10.1371/journal.pone.0112633
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of the tuberculosis (TB) patients from whom the study’s Mycobacterium tuberculosis strains were isolated.
| No. (%) of TB cases | ||||
| Eastern | Southern | |||
| Aborigine | Han Chinese | Aborigine | Han Chinese | |
|
| 47(37.76) | 101(68.24) | 43(23.24) | 142(76.76) |
|
| ||||
| Male | 25(53.19) | 74(73.27) | 31(72.09) | 94(66.2) |
| Female | 22(46.81) | 27(26.73) | 12(27.91) | 48(33.8) |
|
| ||||
| Average | 29.43 | 56.16 | 65 | 67.95 |
| ≦20 years | 28(59.57) | 10(9.90) | 0(0.00) | 1(0.7) |
| 21–40 years | 2(4.26) | 12(11.88) | 5(11.63) | 10(7.04) |
| 41–70 years | 16(34.04) | 50(49.50) | 19(44.19) | 56(39.44) |
| >70 years | 1(2.13) | 29(28.71) | 19(44.19) | 75(52.82) |
Gender and age distribution between aborigines and Han Chinese were significantly different for the eastern region (p = 0.024 and p<0.0001, respectively), but not for the southern region (p = 0.58 and p = 0.6, respectively).
Distribution of strain lineages among MTB isolates in aboriginal and Han Chinese patients from eastern and southern Taiwan.
| No. (%) of strains in each ethnic population | |||||||
| Eastern | Southern | ||||||
| Total | Aborigine | Han Chinese | Total | Aborigine | Han Chinese | ||
|
| 69(46.62) | 24(51.06) | 45(44.55) | 47(25.41) | 8(18.6) | 39(27.46) | |
|
| 9(6.08) | 0(0) | 9(8.91) | 82(44.32) | 20(46.51) | 62(43.66) | |
|
| 39(26.35) | 17(36.17) | 22(21.78) | 28(15.14) | 9(20.93) | 19(13.38) | |
|
| 19(12.84) | 5(10.64) | 14(13.86) | 19(9.73) | 5(11.63) | 13(9.15) | |
|
| 3(2.03) | 0(0) | 3(2.97) | 2(1.08) | 1(2.33) | 1(0.7) | |
|
| 9(6.08) | 1(2.13) | 8(7.92) | 8(4.38) | 0(0) | 8(5.63) | |
Association between cluster rates and M. tuberculosis genotype in aboriginal and Han Chinese populations.
| Whole Population | Beijing | EAI | Haarlem | ||||||||||||||||||
| Region | Group | No. ofpatients | Patients incluster (%) | OR | 95% CI | Pvalue | No. ofpatients | Patientsin cluster (%) | OR | 95% CI | Pvalue | No. ofpatients | Patientsin cluster(%) | OR | 95% CI | Pvalue | No. ofpatients | Patientsin cluster(%) | OR | 95% CI | Pvalue |
|
|
| 148 | 39(26.35) | 69 | 24(34.78) | 9 | 2(22.22) | 39 | 13(33.33) | ||||||||||||
|
| 47 | 24(51.06) | 5.98 | 2.71–13.21 | <0.0001 | 24 | 15(62.50) | 6.67 | 2.21–20.09 | 0.001 | 0 | 0 | NA | NA | 1 | 17 | 9(52.94) | 5.06 | 1.2–21.42 | 0.04 | |
|
| 101 | 15(14.85) |
| 45 | 9(20.00) |
| 9 | 2(22.22) |
| 22 | 4(18.18) |
| |||||||||
|
|
| 185 | 60(32.43) | 47 | 8(17.02) | 82 | 45(54.88) | 28 | 4(14.29) | ||||||||||||
|
| 43 | 10(23.26) | 0.56 | 0.25–1.22 | 0.14 | 8 | 0(0) | 0.22 | 0.01–4.17 | 0.32 | 20 | 8(40.00) | 0.45 | 0.16–1.26 | 0.2 | 9 | 2(22.22) | 2.43 | 0.28–20.82 | 0.57 | |
|
| 142 | 50(35.21) |
| 39 | 8(20.51) |
| 62 | 37(59.68) |
| 19 | 2(10.53) |
| |||||||||
*These logit estimators use a correction of 0.5 in every cell that contains a zero.
Drug susceptibility and resistance to first-line anti-tuberculosis drugs.
| Eastern | Southern | ||||
| Aborigines (n = 47) | Non-aborigines (n = 101) | Aborigines (n = 43) | Non-aborigines (n = 142) | ||
|
| 31(65.96) | 80(79.21) | 38(88.37) | 113(79.58) | |
|
| |||||
|
| 10(21.28) | 16(15.84) | 3(6.98) | 13(9.15) | |
|
| 12(25.53) | 12(11.88) | 2(4.65) | 18(12.68) | |
|
| 7(14.89) | 0(0) | 1(2.33) | 1(0.7) | |
|
| 10(21.28) | 2(1.98) | 1(2.33) | 1(0.7) | |
|
| 9(19.15) | 2(1.98) | 0(0) | 1(0.7)c | |
*P≤0.05 by Fisher exact test comparing drug-resistance percentages between aborigine and non-aborigine populations.
MDR: resistant to at least isoniazid and rifampicin.